Data from: Efficacy and safety of four weeks’ treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial

负责人：

关键词：

RESPIRATORY MEDICINE;Chronic airways disease;THORACIC MEDICINE

DOI：

doi:10.5061/dryad.7p1r30q5

摘要：

in development for chronic obstructive pulmonary disease (COPD) and asthma. TRIAL DESIGN: A multicentre, randomised, double-blind, parallel-gr